Health Coaching for Glaucoma Patients
1 other identifier
interventional
9
1 country
1
Brief Summary
The study will be conducted to examine the feasibility of using a Health Coach for improving the ophthalmic care of glaucoma patients. Patients taking glaucoma medications will have a coaching intervention and adherence to glaucoma drops will be monitored using a dose-recording device. The dosing data will be analyzed to examine the effect on adherence and qualitative interviews at the conclusion of the study will be used to examine which elements of the coaching experience were most helpful in the glaucoma patient population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2014
CompletedFirst Posted
Study publicly available on registry
March 18, 2014
CompletedStudy Start
First participant enrolled
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedResults Posted
Study results publicly available
March 14, 2016
CompletedMarch 14, 2016
January 1, 2016
11 months
March 14, 2014
November 6, 2015
February 17, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Glaucoma Medication Adherence
Glaucoma medication adherence will be tracked using a dose recording device to record eye drop usage. The average of the participants percentage of time they adhered to using the medication will be reported.
6 Months
Study Arms (1)
Health Coach
OTHERHealth Coach is conducted to see if it improves ophthalmic care for glaucoma patients.
Interventions
Eligibility Criteria
You may qualify if:
- Adult whose age is \>18 years
- Diagnosed with glaucoma
- Patient of Duke Glaucoma Service
- Prescribed or using topical glaucoma eye medication for at least 6 months
- Primarily self-administering his or her eye drops
- English speaking
- Patient should be able to use the telephone for the coaching intervention,
- Patient should be available by phone to complete the coaching intervention
- Patient should be willing and able to use the MEMS (Medication Event Monitoring System) device for recording medication use
- Patient must be willing and able to come to the Eye Center for an exit interview and to return the MEMS device
- Patient must be able to give consent
You may not qualify if:
- Patient should be excluded if he or she may need glaucoma surgery or laser during the 6 months of the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke Eye Center
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jullia Rosdahl MD PhD
- Organization
- Duke Eye Center
Study Officials
- PRINCIPAL INVESTIGATOR
Jullia Rosdahl, MD, PhD
Duke University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2014
First Posted
March 18, 2014
Study Start
May 1, 2014
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
March 14, 2016
Results First Posted
March 14, 2016
Record last verified: 2016-01